ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-04-25 8:08:10 AM | Chg. +2.20 | Volume | Bid3:09:22 PM | Ask3:09:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
134.20EUR | +1.67% | 0 Turnover: 0.00 |
139.20Bid Size: 400 | 139.45Ask Size: 400 | 215.38 bill.EUR | - | - |
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...